Perceptions of Physicians on the Diagnosis of Rare Diseases in Europe: Results of a Cross-Sectional Survey

Author(s)

Omri A1, DeCongelio M2, Irfan T3, Sterzi D4, Purinton S2, Le Calvé P5, Mnif T5, Esposito F6, Matos JE7, Reed S8
1Oracle Life Sciences, Chaville, France, 2Oracle Life Sciences, Austin, TX, USA, 3Oracle Life Sciences, Munich, Germany, 4Oracle Life Sciences, Madrid, Spain, 5Oracle Life Sciences, Paris, France, 6All Global, London, UK, 7Rocket Pharmaceuticals, New Jersey, NJ, USA, 8Oracle Life Sciences, Paris, 75, France

OBJECTIVES: To explore perceptions of primary care physicians (PCPs) and specialists regarding the diagnosis pathway of rare diseases in Europe.

METHODS: In May 2024, PCPs and specialists from France, Germany, Italy, Spain, and the United Kingdom (UK) were recruited via physician panels to complete an online survey. Physicians rated their perceptions of the diagnosis pathway of rare diseases using seven-point Likert scale, with results categorized into: Disagree (answers of 1 - 3); Ambivalent (4); and Agree (5 - 7).

RESULTS: Participants included 320 PCPs and 762 specialists: cardiology (82), hematology/oncology (63), dermatology (61), pediatrics (61), pulmonology (61), obstetrics/gynecology (60), endocrinology/diabetology (54), neurology (48), gastroenterology/hepatology (46), rheumatology (46) internal medicine (43), ophthalmology (42), urology (42), nephrology (33) and infectious diseases (20).The proportion of physicians who agreed with the following statements were:

The delay between first symptoms and the diagnosis is more problematic in rare diseases compared to other conditions (88% agreed overall, 87% PCPs, 89% specialists), patient referrals to confirm rare diseases diagnoses take longer (82% overall, 78%, 83%), and referring patients for confirmation of diagnoses involves more difficult decisions (76% overall, 74%, 77%). Physicians agreed that the lack of awareness amongst clinicians is one of the main causes of late/misdiagnosis of rare diseases (78% overall, 74%, 79%). Physicians agreed on the need for more investigation/publication in rare diseases (85% overall, 80%, 86%) and the insufficiency of medical students’ education on rare disease manifestations (71% overall, 71%, 71%). Only 27% of physicians overall agreed on feeling familiar with rare diseases (19% PCPs, 30% specialists).

CONCLUSIONS: There is consensus regarding the challenges in diagnosing rare diseases, and a clear call for increased research and improvements in medical education. Addressing these issues may better equip healthcare professionals in effectively diagnosing and managing rare diseases.

Conference/Value in Health Info

2024-11, ISPOR Europe 2024, Barcelona, Spain

Value in Health, Volume 27, Issue 12, S2 (December 2024)

Code

HSD22

Disease

No Additional Disease & Conditions/Specialized Treatment Areas, Rare & Orphan Diseases

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×